Anti-Mesothelin antibody [K1]

• Supplier: Abcam
• Catalog: ab3362
• Prices: $384.00
• Sizes: 250 µl
• Host: Mouse
• Clonality: Monoclonal
• Isotype: IgG1
• Clone: K1
• Applications: WB IHC-F FC IHC-P
• Species Reactivities: Human, Monkey
• Antigen: Spleen lymphocytes from mice fused with OVCAR-3, an ovarian tumorcell line derived from poorly differentiated adenocarcinoma of the ovary
• Description: Mouse Monoclonal
• Gene: MSLN
• Conjugate: Unconjugated

Product images

All lanes : Anti-Mesothelin antibody [K1] (ab3362) at 1 µg/mlLane 1 : Lung (Human) Tissue LysateLane 2 : Placenta (Human) Tissue Lysate - adult normal tissue (ab29745)Lysates/proteins at 10 µg per lane.SecondaryGoat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/5000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.

Product References

Inhibition of mesothelin as a novel strategy for targeting cancer cells. - Inhibition of mesothelin as a novel strategy for targeting cancer cells.

Wang K, Bodempudi V, Liu Z, Borrego-Diaz E, Yamoutpoor F, Meyer A, Woo RA, Pan W, Dudek AZ, Olyaee MS, Esfandyari T, Farassati F. PLoS One. 2012;7(4):e33214.

Structural analysis of the cancer-specific promoter in mesothelin and in other - Structural analysis of the cancer-specific promoter in mesothelin and in other

Ren YR, Patel K, Paun BC, Kern SE. J Biol Chem. 2011 Apr 8;286(14):11960-9.

Identification of glycoproteins associated with different histological subtypes - Identification of glycoproteins associated with different histological subtypes

Tian Y, Yao Z, Roden RB, Zhang H. Proteomics. 2011 Dec;11(24):4677-87.

Human tumor-derived exosomes down-modulate NKG2D expression. - Human tumor-derived exosomes down-modulate NKG2D expression.

Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z. J Immunol. 2008 Jun 1;180(11):7249-58.

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic - Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic

Li M, Bharadwaj U, Zhang R, Zhang S, Mu H, Fisher WE, Brunicardi FC, Chen C, Yao Q. Mol Cancer Ther. 2008 Feb;7(2):286-96.

Human tumor-derived exosomes selectively impair lymphocyte responses to - Human tumor-derived exosomes selectively impair lymphocyte responses to

Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Cancer Res. 2007 Aug 1;67(15):7458-66.

Mesothelin, a possible target for immunotherapy, is expressed in primary AML - Mesothelin, a possible target for immunotherapy, is expressed in primary AML

Steinbach D, Onda M, Voigt A, Dawczynski K, Wittig S, Hassan R, Gruhn B, Pastan I. Eur J Haematol. 2007 Oct;79(4):281-6. Epub 2007 Sep 4.